Lyytinen, J <br/><br/>
Simultaneous MAO-B and COMT inhibition in L-Dopa-treated patients with Parkinson's disease.  [electronic resource] 

 -  Movement disorders : official journal of the Movement Disorder Society  Jul 1997 
 - 497-505 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0885-3185 
<br/><br/><label>Standard No.: </label>10.1002/mds.870120404  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Analysis of Variance<br/>Antiparkinson Agents--pharmacology<br/>Benserazide<br/>Catechol O-Methyltransferase Inhibitors<br/>Catechols--pharmacology<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Humans<br/>Levodopa--pharmacokinetics<br/>Male<br/>Middle Aged<br/>Monoamine Oxidase Inhibitors--pharmacology<br/>Motor Activity--drug effects<br/>Nitriles<br/>Parkinson Disease--blood<br/>Selegiline--pharmacology